Clinical evaluation of ceftazidime in high risk patients
Montagnani, M.; Bianchini, C.; Nami, R.; Pavese, G.; Papini, L.; Gennari, C.
International Journal of Clinical Pharmacology Therapy and Toxicology 23(7): 376-383
1985
ISSN/ISBN: 0174-4879 PMID: 3897077 Document Number: 263463
Ceftazidime was used in 19 patients at high risk owing to severe impairment of natural defense systems. The therapeutic efficacy and adverse reactions produced by cephalosporin, as evaluated on the basis of the results of clinical investigations and laboratory tests, were regarded as positive.
Document emailed within 1 workday
Related Documents
Cristiano, P. 1989: Clinical evaluation of imipenem/cilastatin in the therapy of severe infections in high-risk patients Drugs under Experimental and Clinical Research 15(1): 17-20Hermanides, R.S.; Ottervanger, J.P.; ten Berg, J.M.; Gosselink, A.T.M.; van Houwelingen, G.; Dambrink, J.-H.E.; Stella, P.R.; Hamm, C.; van 't Hof, A.W.J. 2012: Net clinical benefit of prehospital glycoprotein IIb/IIIa inhibitors in patients with ST-elevation myocardial infarction and high risk of bleeding: effect of tirofiban in patients at high risk of bleeding using CRUSADE bleeding score Journal of Invasive Cardiology 24(3): 84-89
Sato, Y.; Iwata, S.; Kusumoto, Y.; Shiro, H.; Oikawa, T.; Osano, M. 1986: Fundamental and clinical evaluation of ceftazidime in neonates and premature infants Japanese Journal of Antibiotics 39(8): 2084-2096
Sader; Cerbara; Luz; Hashimoto 1999: Evaluation of the Cephalosporins, Cefepime, Cefpirome and Ceftazidime, against Clinical Isolates of Imipenem-Resistant Pseudomonas aeruginosa Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 3(6): 231-237
Farci, G.; Laconi, R.; Lai, M.E.; Balestrieri, A. 1985: Clinical study of 42 patients treated with ceftazidime La Clinica Terapeutica 115(3): 169-172
Overgaard, M. 2000: Evaluation of radiotherapy in high-risk breast cancer patients given adjuvant systemic therapy Rays 25(3): 325-330
Mamedov, I.M.; Erendiev, V.M.; Aliev, S.A. 1989: Comparative evaluation of various approaches to the surgical treatment of cholelithiasis in patients of a high-risk group Khirurgiia 3: 96-99
Nelson, C.; Hitchcock, K.; Bohlen, J.A.; Malaty, W. 2009: Clinical inquiries. what does the evidence tell us about treating very-high-risk patients to an LDL <70 mg/dL? Journal of Family Practice 58(12): 665-667
Ruskin, J.N. 1992: Role of invasive electrophysiological testing in the evaluation and treatment of patients at high risk for sudden cardiac death Circulation 85(1): I152-I159
Sharma, S.K.; Kadhiravan, T.; Banga, A. 2009: A clinical prediction rule to identify patients with tuberculosis at high risk for HIV co-infection Indian Journal of Medical Research 130(1): 51-57
Arunakul, I.-o.; Piyayotai, D. 2010: Incidence of perioperative myocardial infarction among high risk patients who undergo preoperative evaluation for non-cardiac surgery by cardiologists Journal of the Medical Association of Thailand 93(Suppl 7): S171-S176
Pruekprasert, P.; Tunyapanit, W. 2005: In vitro activity of fosfomycin-gentamicin, fosfomycin-ceftazidime, fosfomycin-imipenem and ceftazidime-gentamicin combinations against ceftazidime-resistant Pseudomonas aeruginosa Southeast Asian Journal of Tropical Medicine and Public Health 36(5): 1239-1242
Holt, J.; Stiltner, L.; Wallace, R.; Raetz, J. 2009: Clinical inquiries. do patients at high risk of Alzheimer's disease benefit from early treatment? Journal of Family Practice 58(6): 320-322
Liu, H.; He, G.-s.; Wu, D.-p.; Sun, A.-n.; Shao, Z.-h.; Qian, S.-x.; Xiao, Z.-j.; Ma, J.; Wang, S.-y.; Xu, X.-p.; Liu, T.; Jin, J.; Chen, Z.-c.; Fang, M.-y.; Chen, B.-a.; Xu, L.-p.; Shen, Z.-x.; Ruan, C.-g. 2012: Clinical efficacies and safety of HAG regimen for patients with high-risk myelodysplastic syndromes: a multicentre study Zhonghua Yi Xue Za Zhi 92(10): 689-691
Geng, S.; Feng, F.-z.; Xiang, Y.; Wan, X.-r.; Zhou, Y. 2011: Analysis of prophylactic chemotherapy outcome and clinical characteristics in patients of high-risk hydatidiform mole Zhonghua Fu Chan Ke Za Zhi 46(1): 24-27
Winchester, L.; Acevedo, S.; Guiven, A.; Pabon, M.; Montalvo, F. 2003: Evaluation of patient age as a risk assigment parameter in high risk acute lymphocytic leukemia Boletin de la Asociacion Medica de Puerto Rico 95(1): 26-28; 33-35
Gribova, O.V.; Musabaeva, L.I.; Choĭnzonov, E.L.; Mukhamedov, M.R. 2012: The clinical course of thyroid cancer following its combined treatment with the use of fast-neutron therapy in the patients at the high risk of relapses Vestnik Otorinolaringologii 5: 91-92
Izumikawa, K.; Hashiguchi, K.; Sawai, T.; Inoue, Y.; Imamura, Y.; Seki, M.; Kakeya, H.; Yamamoto, Y.; Yanagihara, K.; Kohno, S. 2009: Study on the blood concentration and clinical efficacy of ceftazidime, a cephem antibiotic at dose of one gram q.i.d, for adult hospital-acquired pneumonia patients Japanese Journal of Antibiotics 62(1): 9-16
Adem, C.; Jenkins, R.B.; Capron, Fédérique.; Stoppa-Lyonnet, D. 2004: High-risk lesions in high-risk women: a high-risk formalin-based biology! Journal of clinical oncology: official journal of the American Society of Clinical Oncology 22(6): 1159-61; author reply 1161-2
Sun, Y.; Wang, J.; Li, J.; Zhang, Y.; Yao, Y. 1995: Evaluation of a tubular mesh and a spiral stent woven from titanium nickel alloy for prostatic obstruction in patients at high risk for surgery. Report of 62 cases Chinese Medical Journal 108(10): 769-773